Atnaujinta: 2024.07.22 07:09 (GMT+3)

Tallinna Farmaatsiatehas: Resolutions of shareholders' annual general meeting

2001.05.29, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATSIATEHAS
ANNOUNCEMENT

RESOLUTIONS OF SHAREHOLDERS' ANNUAL GENERAL MEETING

The annual general meeting of Tallinna Farmaatsiatehase AS shareholders was
held on May 29, 2001, beginning at 11 a.m. at the conference centre of Central
Hotel (Narva St. 7C, Tallinn).

The AGM was attended by 10 shareholders representing 808,231 shares or
64,6585% of the share capital, thus the AGM was eligible to pass resolutions.

The AGM made resolutions as follows:

1.Elect Ms. Anu Uritam as the Chairperson of the meeting.
Elect Mrs. Relika Arras as the Protocoller of the meeting.
Elect Mr. Mait Kivimets as the member of Commission for Counting the Votes.

2.Confirm the Rules of the General Meeting in the wording by Management Board.

3.Confirm the Agenda of the General Meeting according to the published
announcement:
1.KOpening the Meeting. Election of the Chairman of the meeting, the
Secretary of the meeting and the Commission for Counting the Votes.
2.Confirmation of the Rules of the General Meeting.
3.Confirmation of the Agenda of the General Meeting.
4.Report of the Chairman of the Management Board.
5.Report of the Supervisory Council.
6.Approval of the annual financial statement of 2000 and the conclusion
of the auditor.
7.Approval of the profit distribution proposal for the year 2000.
8.Election of the auditor.
9.Other.


4.Approve the annual report for 2000 and the conclusion of the auditor.

5.Approve the proposal for allocation of net profit of 2000.

Distribute the net profit with the total amount of 10,587,118 (ten million
five hundred eighty-seven thousand one hundred eighteen) kroons as follows:

to transfer EEK 2,778,655 to retained earnings account;

to maintain the rest of the net profit of EEK 7,808,463 undivided.

6.Elect Mr. Villu Vaino (identity code 37112180215, residing in Tallinn,
Estonia, auditor licence No. 404, representing the audit enterprise
AS Deloitte & Touche Eesti) to audit the financial reports of Tallinna
Farmaatsiatehase AS in 2001.

Pursuant to item 9 of the AGM agenda Ibraim Muhtshi, chairman of the
Management Board of Tallinna Farmaatsiatehase AS, informed of the decree
no. 74 "Rules for manufacture of medicinal products" approved by the
Minister of Social Affairs. As at July 1, 2001, the aforementioned decree
stipulates that a company manufacturing medicinal products must meet the
traditional fair manufacturing procedures effective in the European Union.
Additional investments are planned for Ointment Department in 2001 to meet
the required traditional fair manufacturing procedures.

The Supervisory Board and Management Board of Tallinna Farmaatsiatehase AS
are considering two possibilities of improving the Tablets Manufacturing
Department:
- additional investments for reconstruction of the existing Tablets Department.
- relocation of manufacture of tablets to a company with a certificate
for fair manufacturing procedures (one possible partner being Grindeks,
shareholder of Tallinna Farmaatsiatehase AS). This alternative would
meet the concern's strategy as well as consolidate concern's
financial resources and output capacities.

The AGM was ended at 11:45 a.m.


Raivo Unt
Financial Director
+372 6120201

Vertybiniai popieriai

Akcijos
Obligacijos
Fondai

Rinkos informacija

Statistika
Prekyba
Indeksai
Aukcionai

Reguliavimas

Taisyklės ir nuostatos
Priežiūra

Kaip pradėti

Įmonėms
Investuotojams
Nariams
First North sertifikuotiems PATARĖJAMS

Naujienos

Nasdaq naujienos
Emitento naujienos
Kalendorius

Apie mus

Nasdaq Baltijos rinkoje
Biurai